Japanese Biotechnology company establishes EMEA hub in Oxfordshire
Amano Enzyme, an international manufacturer of specialty enzymes has established its new Europe, Middle East and Africa (EMEA) hub at Milton Park, a science, technology and business community in Oxfordshire. The Japanese biotechnology company uses its enzymes to boost the flavour, texture, colour, digestion and nutritional profiles of products in the plant-based alternatives market.
It has occupied 5,682 sq ft of office and laboratory space at 25 Western Avenue to drive further company growth. The move to Milton Park coincides with the company’s 30th anniversary in the UK, while 2023 marks its 40th anniversary in Europe, with plans underway for a significant recruitment drive across R&D, sales and customer service roles. This will see Amano nearly double its workforce at Milton Park in the coming years. Amano’s new premises at Milton Park will oversee all operations across its EMEA sites and is also undergoing a state-of-the-art fit-out. Once complete, the bespoke laboratory, comprising cutting-edge R&D equipment, will enable the company to further expand into strategic focus areas, such as plant-based food and drinks.
Paul Britton, Chief Executive of the Thames Valley Chamber of Commerce, commented: “The Thames Valley’s attractiveness as a leading investment location for foreign owned companies is showcased once again through Amano Enzyme’s decision to establish their EMEA hub in Oxfordshire; the company is joining an ecosystem of world-class companies which our region is home to.”
Kazumi Washisaka, managing director at Amano Enzyme, said: “Milton Park offers the space to create bespoke laboratories in close proximity to Reading University’s Food and Nutritional Sciences hub, making it the ideal location for Amano Enzyme’s new EMEA base. Additionally, we were keen to find an innovative work environment with excellent public transport links.”
Washisaka added: “We’re thoroughly looking forward to growing our pipeline of work with the support of these new premises while at the same time networking with the many other pioneering biotechnology companies based at Milton Park.”
To find out more, please click here